This inventor holds 1 USPTO granted patent. Top assignees: Imperial College Innovations Limited, United Kingdom Research and Innovation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 173 
1 out of 77 
Years Active: 2026
Title: Wouter Kallemeijn: Innovator in Liver Disease Treatment
Introduction
Wouter Kallemeijn is a notable inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the treatment of liver diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Wouter Kallemeijn holds a patent titled "NMT Inhibitor Treatment of a Senescence-Associated Disease or Disorder of the Liver." This patent represents a significant advancement in the treatment options available for liver-related conditions. It showcases his commitment to improving healthcare through innovative solutions. He has 1 patent to his name.
Career Highlights
Throughout his career, Wouter has worked with esteemed organizations such as Imperial College Innovations Limited and United Kingdom Research and Innovation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Wouter Kallemeijn has collaborated with notable professionals, including Jesus Gil. These partnerships have enhanced his research and development efforts, leading to impactful innovations in the medical field.
Conclusion
Wouter Kallemeijn is a dedicated inventor whose work in liver disease treatment exemplifies the power of innovation in healthcare. His contributions continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile